TLE1 Activators
TLE1, as part of the Notch transcriptional complex, plays a crucial role in maintaining cellular homeostasis by regulating gene expression. The corepressor function of TLE1 involves its interaction with the intracellular domain of Notch receptors, leading to the suppression of Notch target genes. The class of chemicals identified as TLE1 activators comprises compounds that exert their influence on TLE1 either directly or indirectly through modulation of specific cellular pathways. Among these chemicals, histone deacetylase inhibitors such as Valproic Acid, Trichostatin A, and SAHA play a crucial role in TLE1 activation by promoting histone acetylation. These compounds create an epigenetic environment conducive to TLE1 gene transcription, enhancing its expression within the cellular milieu. Additionally, several chemicals indirectly activate TLE1 by influencing key signaling pathways. For instance, Curcumin and Retinoic Acid impact TLE1 activation by modulating the NF-κB and Wnt pathways, respectively.
Curcumin's inhibition of NF-κB indirectly activates TLE1 by altering the cellular inflammatory state, while Retinoic Acid affects TLE1 through the stabilization of β-catenin in the Wnt pathway. These compounds showcase the intricate network of pathways converging on TLE1 activation. Furthermore, GSK-3 inhibitors such as Lithium Chloride and SB216763 indirectly activate TLE1 by stabilizing β-catenin, impacting the delicate equilibrium of transcriptional co-factors associated with TLE1. The indirect activation of TLE1 is also observed with Nicotinamide, a PARP inhibitor, which modulates chromatin remodeling processes, influencing TLE1 accessibility for transcriptional events.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, a short-chain fatty acid, is known for its role in histone deacetylase (HDAC) inhibition. By blocking HDAC activity, it promotes histone acetylation, leading to chromatin remodeling. This epigenetic modification can indirectly activate TLE1 by enhancing its transcription through accessible chromatin structure. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a polyphenol found in turmeric, exhibits anti-inflammatory properties and modulates various signaling pathways. It indirectly activates TLE1 by inhibiting NF-κB, a transcription factor involved in inflammation. As NF-κB suppression occurs, the downstream transcriptional events influence the cellular environment, potentially leading to TLE1 activation through altered signaling cascades. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a derivative of vitamin A, plays a crucial role in cellular differentiation. It indirectly activates TLE1 by influencing the Wnt signaling pathway. Retinoic acid promotes the degradation of β-catenin, a key player in Wnt signaling, thereby modulating the availability of co-factors for TLE1 in the nucleus, ultimately affecting its activation state. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a potent HDAC inhibitor, can directly impact TLE1 activation by promoting histone acetylation. Through epigenetic modifications, Trichostatin A facilitates a permissive chromatin environment, allowing for enhanced TLE1 gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride, a glycogen synthase kinase-3 (GSK-3) inhibitor, indirectly activates TLE1 by modulating the Wnt signaling pathway. By inhibiting GSK-3, it stabilizes β-catenin, promoting its nuclear translocation and influencing the transcriptional complexes involving TLE1. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3, acts as a PARP inhibitor, impacting cellular processes such as DNA repair. Its indirect activation of TLE1 may occur through the modulation of PARP-mediated chromatin remodeling, influencing the accessibility of TLE1 for transcriptional events. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763, a GSK-3 inhibitor, indirectly activates TLE1 by stabilizing β-catenin and influencing the Wnt signaling pathway. This compound alters the equilibrium of transcriptional co-factors, promoting the formation of complexes involving TLE1 and contributing to its activation state. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a bromodomain inhibitor, indirectly activates TLE1 by disrupting acetylated histone recognition. By interfering with bromodomain-containing proteins, JQ1 modulates the chromatin landscape, potentially favoring TLE1 activation through altered transcriptional regulation. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151, a BET bromodomain inhibitor, indirectly activates TLE1 by disrupting acetylated histone recognition. Through its interaction with bromodomain-containing proteins, I-BET151 modulates the chromatin landscape, potentially favoring TLE1 activation by altering transcriptional regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA, a histone deacetylase inhibitor, directly impacts TLE1 activation by promoting histone acetylation. Through epigenetic modifications, SAHA facilitates a permissive chromatin environment, allowing for enhanced TLE1 gene transcription. | ||||||